Driehaus Event Driven Fund (DEVDX)

The fund aims to deliver consistent positive returns across complete market cycles. It employs an actively managed, event-driven strategy, where its investment advisor seeks to capitalize on identified mispricings or inefficiencies within both U.S. and global equity and fixed-income markets. This fund maintains a non-diversified portfolio.

DEVDX Mutual Fund Chart & Stats

$11.30

At close: Nov 04 4:00 PM EST

Previous Close: $11.30
Sub-Category: Event-Driven
Total Liabilities: $3.95M
Last Dividend Ex-Date: Feb 13, 2026
Expense Ratio: 1.43%
Holding Count: 73
Brand: Driehaus Mutual Funds
Dividend Yield: (16.48%)
Category: Alternative
Total Assets: 93.03M
Shares Outstanding: N/A
52-Week Range: $11.26 - $13.38

DEVDX Mutual Fund News

Hillman Solutions price target lowered to $10 from $11 at Barclays

Barclays lowered the firm’s price target on Hillman Solutions (HLMN) to $10 from $11 and keeps an Equal Weight rating on the shares. Published first on TheFly – the ultimate

8h agoHLMN

Septerna Selects SEP-204 Candidate for Graves’ Disease

Septerna, Inc. ( ($SEPN) ) just unveiled an update. Septerna is a clinical-stage biotechnology company advancing oral small-molecule GPCR drug candidates through its Native Complex Platform, with programs spanning endocrinology,

1d ago8K SEPN

Hillman Solutions price target lowered to $12 from $13 at Canaccord

Canaccord lowered the firm’s price target on Hillman Solutions (HLMN) to $12 from $13 and keeps a Buy rating on the shares. The firm updated its model following Q3 results

1d agoHLMN

Septerna price target raised to $61 from $50 at Wells Fargo

Wells Fargo raised the firm’s price target on Septerna (SEPN) to $61 from $50 and keeps an Overweight rating on the shares following a SEP-479 deep dive. The firm’s cross-program,

1d agoSEPN

Hillman Solutions price target lowered to $10.50 from $12 at Stifel

Stifel analyst W. Andrew Carter lowered the firm’s price target on Hillman Solutions (HLMN) to $10.50 from $12 and keeps a Buy rating on the shares. Published first on TheFly

1d agoHLMN

Xenon to Present at Four Healthcare Investor Conferences

Xenon ( ($XENE) ) has issued an update. Xenon Pharmaceuticals announced participation in four healthcare investor conferences during the fourth quarter of 2026, with fireside chats scheduled in Boston, New

1d agoXENE XP0

Xenon to Report Third-Quarter 2026 Results November 9

Xenon ( ($XENE) ) has shared an update. Xenon Pharmaceuticals announced that it will release its third-quarter 2026 financial results and provide a business update on November 9 after U.S.

2d agoXENE XP0

Hillman Solutions reports Q3 adjusted EPS 22c, consensus 21c

Reports Q3 revenue $457.49M, consensus $462.15M. “The third quarter reflects the continued execution of Hillman’s Blueprint for Strategic Growth,” commented Hillman’s CEO, Jon Michael Adinolfi. “We continue to deliver net

2d agoHLMN EARNINGS

Hillman Solutions cuts FY26 revenue view to $1.66B-$1,68B from $1.67B-$1.72B

Consensus $1.68B. Backs FY26 adjusted EBITDA view $285M. Backs FY26 free cash flow view $105M-$115M. The company said, “Given our performance through the first nine months, we are reaffirming our

2d agoHLMN EARNINGS

Hillman Solutions Corp. (HLMN) Q3 Earnings Cheat Sheet

Hillman Solutions Corp. (HLMN) is scheduled to report 3rd quarter earnings on 11/02/2026, after the market closes. Regarding Q3 estimates, Wall Street analysts expect Hillman Solutions Corp. to post earnings

5d agoHLMN

K&F Growth Acquisition adjusts meeting and redemption timeline

The latest update is out from K&F Growth Acquisition Corp. II Class A ( ($KFII) ). K&F Growth Acquisition Corp. II has entered into non-redemption agreements with certain investors in

5d ago8K KFII

Xenon Advances Non-Opioid Pain Programs After Positive Phase 1 Results

Xenon ( ($XENE) ) has shared an announcement. Xenon Pharmaceuticals reported positive Phase 1 results and new preclinical findings for its ion channel modulators XEN1701 and XEN1120, supporting their progression

1w agoXENE XP0

Sponsor Converts Class B Shares, Aligning SPAC Interests

K&F Growth Acquisition Corp. II Class A ( ($KFII) ) has shared an announcement. On October 23, 2026, K&F Growth Acquisition Corp. II converted 9,583,332 Class B ordinary shares held

1w ago8K KFII

K&F Growth II Plans Pearl AI Wedding Spin-Off

An update from K&F Growth Acquisition Corp. II Class A ( ($KFII) ) is now available. On October 22, 2026, David’s Bridal and K&F Growth Acquisition Corp. II announced a

2w ago8K KFII

Top 10 Holdings

The fund's ten largest positions
Name	Weight %
USD_CASHNorthern Institutional Funds	16.87%
XENEXenon Pharmaceuticals	5.52%
USD_CASHVistra Corp	5.08%
CRNXCrinetics Pharma	4.46%
USD_CASHDanaos Corp.	3.94%
SEPNSepterna, Inc.	3.91%
USD_CASHGenworth Financial Inc.	3.83%
USD_CASHNRG Energy, Inc.	3.60%
HLMNHillman Solutions Corp.	2.64%
KFIIK&F Growth Acquisition Corp. II Class A	2.48%
Total	52.32%

Go to Holdings >